发明名称 Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists
摘要 Compounds having the structural formula I or a pharmaceutically acceptable salt thereof, wherein R is optionally substituted phenyl, furanyl, thienyl, pyridyl, pyridyl N-oxide, oxazolyl or pyrrolyl, or cycloalkenyl R1, R2, R3, R4 and R5 are H, alkyl or alkoxyalkyl; and Z is optionally substituted aryl or heteroaryl are disclosed. Also disclosed is the use of compounds of formula I in the treatment of central nervous system diseases, in particular Parkinson's disease, alone or in combination with other agents for treating Parkinson's disease, and pharmaceutical compositions comprising them.
申请公布号 US7709492(B2) 申请公布日期 2010.05.04
申请号 US20050108916 申请日期 2005.04.19
申请人 SCHERING CORPORATION 发明人 NEUSTADT BERNARD R.;HAO JINSONG;LIU HONG;BOYLE CRAIG D.;CHACKALAMANNIL SAMUEL;SHAH UNMESH G.;STAMFORD ANDREW;HARRIS JOEL M.
分类号 A01N43/54;A61K31/505;A61K31/519;C07D239/00;C07D487/08;C07D487/14 主分类号 A01N43/54
代理机构 代理人
主权项
地址